EV/EBITDA
-0.87
-0.10-12.99%
Wed, 19 Feb 2025 22:13:20 GMT
Summary
- As of February 20, 2025, MRKR EV/EBITDA is -0.87, with a fall of -0.10 (-12.99%) during the most recent trading day.
- Over the past year, MRKR EV/EBITDA has increased by +0.59 (+40.41%).
- MRKR EV/EBITDA is now -131.29% below its all-time high of 2.78.
Performance
MRKR EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
MRKR EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -13.0% | +13.7% | +6.4% |
| 1 m1 month | +48.8% | -48.8% | -32.1% |
| 3 m3 months | +54.5% | -54.4% | -47.6% |
| 6 m6 months | +60.8% | -63.6% | -53.7% |
| ytdytd | +63.5% | -63.5% | -46.3% |
| 1 y1 year | +40.4% | -58.3% | -59.2% |
| 5 y5 years | +75.8% | -88.9% | -93.8% |
MRKR EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -14.5% | -1.70 | +48.8% | |
| 3 m | 3-month | -0.76 | -14.5% | -3.49 | +75.1% |
| 6 m | 6-month | -0.76 | -14.5% | -3.49 | +75.1% |
| 1 y | 1-year | -0.76 | -14.5% | -4.13 | +78.9% |
| 3 y | 3-year | 0.21 | -514.3% | -4.13 | +78.9% |
| 5 y | 5-year | 0.21 | -514.3% | -8.44 | +89.7% |
| alltime | all time | 2.78 | -131.3% | -29.19 | +97.0% |
Marker Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.87(-63.4%) |
| 2024 | -2.38(+3.9%) |
| 2023 | -2.29(+387.2%) |
| 2022 | -0.47(-64.7%) |
| 2021 | -1.33(-43.6%) |
| 2020 | -2.36(-40.6%) |
| 2019 | -3.97(+207.8%) |
| 2018 | -1.29(-59.3%) |
| 2017 | -3.17(+5.3%) |
| Date | Value |
|---|---|
| 2016 | -3.01(+186.7%) |
| 2015 | -1.05(+483.3%) |
| 2014 | -0.18(-89.3%) |
| 2013 | -1.68(-15.2%) |
| 2012 | -1.98(-69.6%) |
| 2011 | -6.51(+93.8%) |
| 2010 | -3.36(-263.9%) |
| 2009 | 2.05(-545.7%) |
| 2008 | -0.46 |
FAQ
- What is Marker Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Marker Therapeutics?
- What is MRKR EV/EBITDA year-to-date change?
- What is Marker Therapeutics EV/EBITDA year-on-year change?
What is Marker Therapeutics EV/EBITDA?
The current EV/EBITDA of MRKR is -0.87
What is the all time high EV/EBITDA for Marker Therapeutics?
Marker Therapeutics all-time high EV/EBITDA is 2.78
What is MRKR EV/EBITDA year-to-date change?
Marker Therapeutics EV/EBITDA has changed by +1.51 (+63.45%) since the beginning of the year
What is Marker Therapeutics EV/EBITDA year-on-year change?
Over the past year, MRKR EV/EBITDA has changed by +0.59 (+40.41%)